BILVAVALEHA IN AUTISM (IMPROVE THE SOCIAL BEHAVIOR)

TO EVALUATE THE EFFICACY OF BILVAVALEHA IN THE MANAGEMENT OF AUTISM SPECTRUM DISORDER IN CHILDREN

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/01/022803

Enrollment

Registered

2020-01-16

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F949- Childhood disorder of social functioning, unspecified

Interventions

Intervention1: BILVAVALEHA IN THE MANAGEMENT OF AUTISM SPECTRUM DISORDER IN CHILDREN: BILVAVALEHA WILL BE GIVEN ORALLY Control Intervention1: NILL: NILL

Eligibility

Inclusion criteria

Inclusion criteria: 1.PRE DIAGNOSED ASD CHILDREN BELONGINGN TO THE AGE GROUP OF 5 TO 16YEARS, IRRESPECTIVE OF GENDER, RELIGION AND SOCIOECONOMIC STATUS. 2.PARENTS/GUARDIAN WILLING TO GIVE INFORMED WRITTEN CONSENT TO PARTICIPATE IN THE STUDY.

Exclusion criteria

Exclusion criteria: 1.CHILDREN BELOW 5 YEARS AND ABOVE 16 YEARS. 2.PRESENCE OF ORGANIC NEUROLOGICAL DISORDERS. 3.HEARING AND VISUAL IMPAIRMENT, MULTIPLE DISABILITES. 4.PATIENTS WITH ACUTE AND CHRONIC SYSTEMIC ILLNESS SUCH AS RENAL DISEASES, HEPATIC DYSFUNCTION, JUVENILE DIABETES MELLITUS, MALIGNANCY, ect. 5.PROGRESSIVE AND NON PROGRESSSIVE NEUROMUSCULAR DISORDERS, KNOWN NEURODEGENRATIVE DISORDER, CEREBAL PALSY. 6.CHILDREN TAKING ANTI-EPILECTIC AND ANTI-PSYCHOTIC DRUGS.

Design outcomes

Primary

Measure	Time frame
ASSESSMENT EVERY 32 DAYS DURING STUDYTimepoint: TOTAL STUDY IS OF 96 DAYS	—

Secondary

Measure	Time frame
NILLTimepoint: NILL	—

Countries

India

Contacts

Public ContactDR JASMINE

PARUL INSTITUTE OF AYURVED

rajanishsm@gmail.com9986660145

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026